PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 62: Articles 30501-31000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Task force on acceptability research in family planning.
  2. Testosterone enanthate a possible reversible male contraceptive.
  3. Tetrapeptide contraceptive discovery under study.
  4. Thailand: family planning program exceeds targets.
  5. Theories of attitude change and the "beyond family planning" debate: the case for the persuasion approach in population policy.
  6. Think tank's recommendations related to overseas family planning issues.
  7. Three demographic characteristics of current users of contraception.
  8. Three-month treatment cycles for oral contraception? [Drei-Monats-Behandlungszyklen zur oralen Kontrazeption?]
  9. Thyroid function tests and oral contraceptives. (Letter)
  10. To what extent are midwives and traditional birth attendants involved in maternal and child health/family planning services.
  11. Tonga: family planning survey.
  12. A training and motivation strategy for family planning.
  13. Training in communication for family planning: retrospect and prospects.
  14. Training of medical personnel in the field of family planning. [La formation du corps medical en matiere de planification familiale.]
  15. Training village midwives for family planning services delivery in rural Turkey.
  16. Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin.
  17. Transitory changes in the heart action with intrauterine contraceptive devices insertion (author's transl) [Tranzitorne promjene sreane akcije pri uvodenju intrauterinih kontracepcijskih ulozaka.]
  18. Translocated intra-uterine contraceptive devices and missing strings.
  19. Translocation of the intrauterine contraceptive device: study of thirty-one cases.
  20. Transmural myocardial infarction in young women taking oral contraceptives: evidence of reduced regional coronary flow in spite of normal coronary arteries.
  21. Treatment of bartholin gland's abcesses with the use of contraceptive loop (IUD) (author's transl) [Leczenie ropni gruczola Bartholina z sastosowaniem petli antykoncepcyjnej.]
  22. Treatment of menstrual epilepsy with a progesterone-only oral contraceptive.
  23. Trichomonadosis and intrauterine contraceptives (author's transl) [Rzesistkowica a wewiatrzmaciezne srodki antykoncepcyjne.]
  24. (Trip report on family planning in China.)
  25. Trophoblastic tumour, oral contraceptive therapy and pregnancy associated alpha2-glycoprotein (PAAG), case report.
  26. Tubal pregnancy and oral contraception (Letter) [Tubale swangerskap nieteenstaande orale kontrasepsie.]
  27. Tubal pregnancy despite oral contraception. (Letter)
  28. The Tunisian experience in family planning. [L'experience tunisienne de planning familial.]
  29. The Tunisian family and contraception: facts and motivations. [La famille tunisienne et la contraception: donnees et motivations.]
  30. Two years experience with Copper-T at the Urban Family Welfare Centre of Regional Health and Family Planning Training Centre, Hyderabad.
  31. Types of hepatocellular damage caused by hormonal contraceptives. [Typy uszkodzen watroby po hormonalnych srodkach antykoncepcyjnych.]
  32. Ultrasound as a new method of male contraception.
  33. Ultrasound localization of intrauterine contraceptive device.
  34. The ultrastructure of the endometrium during low dose gestagenic contraception. [Ultrastruktura endometria pri nizkodavkovane gestagenni antikoncepci.]
  35. Updata: risk-benefit ratio in contraception.
  36. Use of an injectable contraceptive in delivery of family planning services to some rural communities of northern Thailand.
  37. Use of cervical mucus, temperature to be investigated as a family planning method.
  38. Use of local resources for programs of communication in family planning. [Empleo de recursos locales para los programas de communicaciones en planificacion familiar.]
  39. The use of oestrogens for postcoital contraception.
  40. The use of photo-strips in family planning education.
  41. Use of the family planning clinic record for program management and evaluation.
  42. Using the media for family planning: a professional development module.
  43. Utilization of family planning services by currently married women 15-44 years of age, United States, 1973,.
  44. Utilization of folk media in education. Programs on MCH and family planning by the Centre d'Hygiene Familiale, Port-au-Prince, Haiti.
  45. Utilization of folk media in the education of Haitian communities in family planning.
  46. Vaginal contraception. [Intravaginale Kontrazeption.]
  47. Vaginal contraceptives as prophylaxis against gonorrhea and other sexually transmissible diseases.
  48. Vaginal delivery of contraceptive drugs.
  49. Vaginal spermicides: the contraceptive that improves vaginal health.
  50. The value of volunteers in family planning clinics.
  51. Various problems in connection with the use of contraceptives. [Nagra problem i samband med bruket av preventivmedel.]
  52. Vascular defects in human endometrium caused by intrauterine contraceptive devices: an electron microscopic study.
  53. Vasculorenal risks of oral contraceptives. [Risque vasculo-renal des contraceptifs oraux.]
  54. Vasectomy - the alternative of the male for birth control? [Vasektomie - Die Alternative des Mannes zur Geburtenkontrolle?]
  55. A vasectomy service in a free-standing family planning center: one year's experience.
  56. Vending machine contraceptive distribution: a cost-effective alternative.
  57. Very young adolescent women in Georgia: has abortion or contraception lowered their fertility?
  58. Village family planning: the Indonesian model.
  59. Virginians tune-in to family planning.
  60. Vitamin E status of young women on combined-type oral contraceptives. (Abstract only)
  61. Voice changes during hormonal contraception (authors' transl) [Prispevok k studiu zmien hlasu pri hormonalnej antikoncepcii.]
  62. Weighing risks and benefits of contraceptives.
  63. WFS Modules: Abortion--Factors other than Contraception Affecting Fertility--Family Planning--General Mortality.
  64. What is new in gynecology? Contraception by injection of depot progestogens every 3 months: interest and indications of the method. [Quoi de neuf en gynecologie? La contraception par injection trimestrielle de progestatifs-retard: interet et indications de la methode.]
  65. What's a family planning buffalo?
  66. When a contraceptive doesn't.
  67. Who decides to practice family planning and how?
  68. Working with nature: organic birth control.
  69. World Fertility Survey, Pakistan: unwanted fertility high, contraceptive knowledge and practice low.
  70. World Fertility Survey, Pakistan: unwanted fertility is high while contraceptive access and practice are minimal.
  71. Yugoslavia: Socialist Republic of Slovenia: abortion, sterilization, contraception, and artificial insemination.
  72. Zinc excretion in young women on low zinc intakes and oral contraceptive agents.
  73. Aspects of birth control. [Aspekte zur Geburtenplanung.]
  74. Contraception and fertility in Morocco and Tunisia.
  75. Contraception with d-norgestrel silastic rods. Plasma levels of d-norgestrel and influence on the ovarian function.
  76. Cost-benefit analysis of the family planning programme in Andhra Pradesh (1963-74)
  77. Does oral contraception cause cancer? [Begunstigt die ''Pille'' Krebs?]
  78. Etinodiene 0.5, an oral estro-progestinic contraceptive. [Etinodiene 0,5, anticoncezionale orale estro-progestinico.]
  79. Experience with the IUD in the family planning program of the Secretary of Health and Assistance (Ministry of Health) 1973-1974. [La experiencia con el dispositivo intrauterino en el Programa de Planificacion Familiar de la Secretaria de Salubridad y Asistencia 1973-1974.]
  80. Hepatocellular adenoma: relationship to oral contraceptives? (Letter to the editor)
  81. Individual choice of intrauterine anticonceptive means for contraceptives. [Individualnyi vybor vnutrimatochnykh protivozachatochnykh sredstv dlya kontratseptsii.]
  82. Intrauterine contraceptive devices: mode of action, experiences, complications. [Das Intrauterinpessar zur Kontrazeption: Wirkungsweise, Erfahrungen, Kom plikationen.]
  83. Knowledge and use of herbal contraceptives in a Peruvian Amazon Village.
  84. New more effective model of intrauterine contraceptive loop covered with copper wire--TC200 (author's transl) [Nou po-efectivien model intrauterinien contrat septivien piessar, pocrit s miedna nichka--TC200.]
  85. Oral contraceptives and thromboembolism. [Letter]
  86. Technical cooperation in family health and in family planning. [Cooperation technique dans de domaine de la sante familiale et de la planification familiale.]
  87. Thrombosis: perspective on a major side effect of oral contraceptives. [Letter]
  88. Postcoital contraception: an appraisal./Contracepcao post-coitum : avaliacao./La contraception post-coitale : une evaluation.
  89. Contraception, past, present, and future.
  90. Contraception.
  91. Contraception.
  92. Contraception.
  93. Contraception: review of methods and their effectiveness.
  94. Contraception: the point. [La contraception: le point.]
  95. Contraceptive agents from cycloaddition reactions of diarylcyclopropenones and diarylthiirene 1,1-dioxides.
  96. Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ.
  97. Contraceptive choices for Latin American women.
  98. Contraceptive counseling of adolescents) [Die antikonzeptionelle Beratung Jugendlicher.]
  99. Contraceptive development for developing countries: unmet needs.
  100. Contraceptive development in industry and the public sector.
  101. Contraceptive devices.
  102. Contraceptive distribution and family planning at community and household levels: institutional barriers and evaluation strategies.
  103. Contraceptive dynamism.
  104. Contraceptive efficacy of once-weekly oral administration of 2.5 mg R 2323.
  105. Contraceptive efficacy of two different metals using a modified seven vector.
  106. Contraceptive foams.
  107. Contraceptive inundation: a new family planning strategy. [Tables]
  108. Contraceptive knowledge and practice among undergraduates at a Canadian university.
  109. Contraceptive methods.
  110. Contraceptive pill-induced porphyria cutanea tarda presenting with onycholysis of finger nails.
  111. Contraceptive practices in an adolescent health center.
  112. Contraceptive progress in Latin America and the Caribbean. [Adelantos anticonceptivos en American Latina y el Caribe.]
  113. Contraceptive protection on switching from normal-dose to lower-dose OC preparations.
  114. Contraceptive service delivery in the Singapore National Programme.
  115. Contraceptive services and discussions of birth control.
  116. Contraceptive steroid toxicology in the Beagle dog and its relevance to human carcinogenicity.
  117. Contraceptive steroids and breast cancer. (Abstract only)
  118. 74 requests for termination of pregnancy after failure of oral contraception; some reflections. [74 demandes d'interruption de grossesse sur echec de la contraception orale; quelques reflexions.]
  119. Abortion in 1975: the psychiatric perspective, with a discussion of abortion and contraception in adolescence.
  120. Abortion, failure of contraception. [Avortement, echec de la contraception.]
  121. Accidental drowning ascribed to the use of an oral contraceptive.
  122. Action now: medical aspects in family planning.
  123. Action of a midcycle contraceptive (R 2323) on the human endometrium.
  124. Action research for family planning program management and improvement: scope and limitation.
  125. Acute femoropopliteal ischemia followed by amputation in a woman on oral contraceptives. (letter to the editor. [Ischemie aigue femoro-poplitee suivie d'amputation chez une femme sous contraceptifs oraux.]
  126. Acute ulcerative colitis with spontaneous regression. A new side effect of contraceptives. [Akut colitis ulcerosa - spontan regressioval. A hormonalis anticonceptio ujabb mellekhatasa?]
  127. Adenocarcinoma of the endometrium in women taking sequential oral contraceptives.
  128. Adenoma of the liver and oral contraceptives. [Leveradenoom en orale anticonceptiva.]
  129. Advances in contraception.
  130. Adverse effects of intrauterine contraception and fertility control (Editorial) [Bivirkninger af intrauterin kontraception og fertilitetskontrol.]
  131. Advice on contraception at a venerology clinic. [Preventivmedelsradgivning pa en venereologmotttagning.]
  132. The aerobic flora of the perivaginal area: its relation to contraception and deodorant sprays.
  133. After miniaturization to the limit a double phase estroprogestin with early reinforcement: (result of a study of a new contraceptive based on d-Norgestrel) [Apres la miniaturisation "au plancher" 1'oestro-progestatif a double palier et a renforcement precoce: (resultats d'un etude avec un nouveau contraceptif a base de d-Norgestrel)]
  134. Aggravation of hypertension in rats chronically pretreated with contraceptive steroids. (Abstract only)
  135. Agricultural approach to family planning.
  136. Agricultural development and family planning.
  137. Aide-memoire: Workshop on Reducing Fertility through Beyond Family Planning measures.
  138. Albany (NY) Health Region Family Planning Survey: factors underlying religious and socioeconomic differences in period fertility.
  139. Altered patterns of thyroid hormones in serum and urine in pregnancy and during oral contraceptive therapy.
  140. Alternative management programmes for middle and upper level managers in family planning programmes: an assessment and some recommendations.
  141. Alternative strategies in implementation of family planning programmes - an experimental project: progress and problems.
  142. Amenorrhea after hormonal contraception, prophylaxis, findings and therapy. [Amenorrho nach hormonaler Antikonzeption, Prophylaze, Befunde und Therapie.]
  143. Amenorrhea following oral contraception.
  144. Amenorrhoea after oral contraceptives.
  145. The American Home Economics Association International Family Planning Project Participant Follow-up Survey.
  146. Analysis and report of the project "evaluation of videotape recorders in family planning information".
  147. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.
  148. An analysis of mass communication activities in family planning programme in Uttar Pradesh.
  149. Analytical assessment of implementation systems for family planning programme in Singapore.
  150. Anthropometric measures in relation to oral contraceptive use.
  151. Antigens of the ovum as a potential basis for the development of contraceptive vaccine.
  152. Antithrombin III and fibrinolysis during pregnancy and oral contraceptive therapy. [Antithrombin III og fibrinolyse under graviditet og peroral antikonceptions behandling.]
  153. An appraisal of the role of the intra-uterine contraceptive device for family planning in Malaysia.
  154. An approach to the analysis of menstrual patterns in the critical evaluation of contraceptives.
  155. Approaches and perspectives in the development of anti-sperm immunity as a contraceptive principle.
  156. Approaches to chemical contraception improvement.

     

  157. Arab folklore: possibilities of utilization in population education and family planning.
  158. Are oral contraceptives and diethylstilbestrol (DES) involved in sex-linked cancer?
  159. Ascorbic acid status of young women using oral contraceptive agents. (Abstract only)
  160. Asian women and their contraceptive problems.
  161. An assessment of family planning service programs in 21 selected countries.
  162. An assessment of family planning service programs in 21 selected countries: the Family Health Care Report.
  163. Assessment of separate domiciliary family planning services.
  164. An assessment of the side effects of switching from one oral contraceptive to another.
  165. Association between liver adenomas and oral contraceptives. (Letter)
  166. An association between the Dalkon shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device-related disorders.
  167. Association of liver tumors with oral contraceptives.
  168. Attempt for a better public education in family planning and prevention. [Tiltak for a bedre folkeopplysningen om familieplanlegging og prevensjon.]
  169. Attitude toward family planning.
  170. Attitudes of mothers of new-born babies towards family planning.
  171. Attitudes to different methods of birth control.
  172. Attitudes toward family planning in Southern Nigeria.
  173. Avenues for further research in family planning.
  174. Awareness, knowledge, and practice of family planning.
  175. Bacterial flora of the endometrial cavity with intrauterine contraceptive devices.
  176. Behavior of blood pressure during oral hormonal contraception. [Das Blutdruckverhalten unter oraler hormonaler Antikonzeption.]
  177. Behavior of heparinocytes and fibrinolytic fission-products after cessation of oral contraceptives. [Verhalten der Heparinozyten und der fibrinolytischen Spaltprodukte nach Absetzen hormonaler Kontrazeptiva.]
  178. Behavior of overall complement as a humoral parameter of unspecific resistance in hormonal contraception. [Zum Verhalten des Gesamtkomplements als einem humoralen Parameter der unspezifischen Resistenz bei hormonaler Kontrazeption und Schwangerschaft.]
  179. Benefit-cost analysis and family planning programs.
  180. Benign focal nodular hyperplasia of the liver without oral contraception.) (Letter to the editor. [Hyperplasie nodulaire focale benigne du foi sans contraception orale.]
  181. Benign hepatic tumors and oral contraceptive pills.
  182. Benign hepatic tumors and their association with oral contraceptives: case reports and survey of the literature.
  183. Benign hepatic tumors secondary to oral contraceptives.
  184. Benign hepatomas and oral contraceptives. [Tumeurs benignes du foie et contraceptifs oraux.]
  185. Benign liver cell adenoma associated with use of oral contraceptive agents.
  186. Benign liver cell adenomas in women using oral contraceptives.
  187. Benign liver tumor after oral contraceptives (Letter) [Tumeur benigne du foie apres contraceptifs oraux.]
  188. Benign liver tumor in a patient taking contraceptive steroids.
  189. Benign liver tumors: What is their relationship to oral contraceptives?
  190. Beyond population, beyond family planning: the Commission on Population's total integrated development approach.
  191. Bibliography on human reproduction, family planning and population dynamics--annotated articles and unpublished work in the South-East Asia Region, special supplement No. 7, 1976 on abortion (including review of current status)
  192. Bibliography on human reproduction, family planning and population dynamics: annotated articles and unpublished work in the South-East Asia Region. Special Suppl. No. 8, 1976.
  193. Bibliography on human reproduction, family planning and population dynamics: annotated articles and unpublished work in the South-East Asia Region: sterilization-male and female (including review of current status)
  194. Bioavailability of contraceptive steroids from capsules.
  195. Biochemical basis for the "riboflavin defect" associated with the use of oral contraceptives. A study in female rats.
  196. Biochemical effects of oral contraceptives.
  197. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat.
  198. Biograviplan Grunenthal: a new system for contraception. [Biograviplan Grunenthal: ein neues System zur Kontrazeption.]
  199. Biological and genetic consequences of family planning in Hungary. [A csaladtervezes biologiai es genetikai kovetkezmenyei Mangyarorszagon.]
  200. Biological effects of oral contraceptives. [Les incidences biologiques des contraceptifs oraux.]
  201. Birth control among postpartum Thai women.
  202. Birth control and genetic changes in Chile. (Letter to the editor)
  203. Birth control and the physician: what is known.
  204. The birth control cultural value complex.
  205. Birth control information (Editorial) [Voortplantingsvoorligting.]
  206. Birth control literature and the medical profession in nineteenth century America.
  207. Birth control services...a plan for change: a study of some women at-risk of experiencing unplanned pregnancies, in order to devise suitable methods of birth control education, and service delivery.
  208. Birth control.
  209. Birth control. [O controle da natalidade.]
  210. Birth control: report argues new leads are neglected.
  211. Black organizations strongly support family planning, but oppose any form of coercion, incentives.
  212. Blame MD "mismanagement" for contraceptive failure.
  213. Blastocidal and contraceptive actions by an extract and compounds from endod (Phytolacca dodecandra)
  214. Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives. [Beeinflussung von Blutgerinnung und Fibrinolyse durch Oestrogen, Gestage n und eine Oestrogen-Gestagen-Kombination.]
  215. Blood coagulation studies and the effect of oral contraceptives in patients with sickle cell anemia. (Abstract only)
  216. Blood pressure in women taking oral contraceptives.
  217. The Brazilian experience: training of volunteers for the distribution of contraceptives in the community. [La experiencia Brasilena: Adiestramiento de voluntarios para la distribucion comunitaria de anticonceptivos.]
  218. Breast feeding: a motive for family planning.
  219. Breastfeeding as a contraceptive method among a low income group of Tehrani women.
  220. Brief guide to office counseling: discontinuing contraception at menopause.
  221. Britain to institute non-medical distribution of contraceptives?
  222. The bromsulphthalein excretion test in women receiving pill-a-month and injection-a-month steroid contraceptives.
  223. Budd-Chiari syndrome and oral contraceptives. [Syndrome de Budd-Chiari et contraceptifs oraux.]
  224. Budd-Chiari syndrome and oral contraceptives. [Syndrome de Budd-Chiari et contraceptifs oraux.]
  225. Buddhism, preference for sons and attitudes toward family planning in rural Thailand.
  226. Bulk of family planning appropriations concentrated in a few states.
  227. Can young woman with vaginal or cervical adenosis take oral contraceptives?
  228. Carbohydrate metabolism of Indian women taking steroid contraceptives.
  229. Carcinoma of the cervix in oral contraceptive steroid and IUD users and nonusers.
  230. Cardiovascular mortality trends and oral contraceptive use in young women. (Abstract only)
  231. Cardiovascular-disease mortality trends and oral-contraceptive use in young women.
  232. Catholic philosophy on contraception.
  233. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive.
  234. Cerebrovascular lesions and oral contraceptives.
  235. Cervical bacterial flora in women fitted with a copper-releasing intra-uterine contraception device (IUD)
  236. Cervical cancer and contraceptive pill use - a case-control study. (Abstract only)
  237. Cervical cancer screening in a Johannesburg family planning centre.
  238. Cervical gonorrhea in women using different methods of contraception.
  239. The cervix and contraception: the future.
  240. Changed levels of endogenous sex steroids in women on oral contraceptives.
  241. Changes in lipid and carbohydrate metabolism and in biliary function during oral contraception and pregnancy. [Modifications des metabolismes glucidique et lipidique et de la fonction biliaire sous oestro-progestatifs et au cours de la grossesse.]
  242. Changes in sexual drives of patients on oral contraceptives.
  243. Changes in some metabolic pathways in women ingesting gestagen preparations for contraception. [Zmiany w niektorych metabolizmach ustrojowych kobiet stosujacych preparaty gestagenowe dla celow antykoncepcyjnych.]
  244. Changes in the world's laws on voluntary sterilization for family planning purposes since January 1973.
  245. Changing contraceptive laws in New York State.
  246. Changing women's roles and family planning in Lebanon.
  247. Choice of an oral contraceptive.
  248. Cholesterol saturation of gallbladder bile may be oral contraceptive-gallstone connection.
  249. Choosing methods for family planning.
  250. Chorea and oral contraceptives. [Choree et prise d'anticonceptionnels.]
  251. Chorea minor in a patient on oral contraception. [Chorea minor unter Ovulationshemmern.]
  252. Chromosome studies in women who had used oral contraceptives and in their progeny. (Abstract only)
  253. Church versus state: family planning in Colombia, 1966-1972.
  254. Cigarette smoking, use of oral contraceptives, and myocardial infarction.
  255. Clinic information, education and communication: a training module for family planning workers.
  256. Clinical and biochemical investigations of an ultra low-dose combined type oral contraceptive.
  257. Clinical and morphological studies in patients with a progesterone-releasing intrauterine contraceptive device (Progestasert system) [Klinische und morphologische Untersuchungen bei Patientinnen nach Einlage eines gestagenhaltigen Intrauterinpessars Progestasert system.]
  258. Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives.
  259. Clinical experience with intrauterine devices as a means of contraception in Kanawha County, West Virginia.
  260. Clinical experiences with birth control in Poland. (Editorial)
  261. Clinical investigation of a very low dosage oral contraceptive combination: 0.75 mg lynestrenol and 0.0375 mg ethinyl oestradiol.
  262. Clinical significance of organic deposits on intrauterine contraceptive devices. [Klinicko znacenje organskih naslaga na kontraceptivnim uterinim uloscima.]
  263. Clinical study of medroxyprogesterone in family planning programs. Latin America and the Caribbean.
  264. Clinical trial of a modified sequential (7-15 biphasic) oral contraceptive.
  265. Clinical trials in reversible male contraception: 1. Combination of danazol plus testosterone.
  266. A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
  267. Clinicopharmacology of Continuin (0.5 mg ethynodioldiacetate), a contraceptive agent.
  268. Coagulation, fibrinolysis and platelet function in Asian women using oral steroid contraceptive.
  269. A college contraceptive clinic.
  270. Colposcopy screening for cervical cancer in a family planning program.
  271. Comments on liver tumors in users of oral contraceptives]
  272. Commercial contraceptive marketing development in Bangladesh. Annual report, June 20, 1975 to June 20, 1976.
  273. Communications and non-formal education in population/family planning.
  274. Communications for social marketing: a methodology for developing communication appeals for family planning programs.
  275. Community and household distribution of contraceptives reaching village women in doctor-short Asian countries.
  276. Community based distribution of contraceptives in Honduras: preliminary report.
  277. Community based distribution of contraceptives in the rural zone of Caaguazu, Paraguay.
  278. Community education approaches for family planning in China.
  279. Community education programme for family planning in Hawaiian-Philippines company.
  280. A community family planning program in the "San Carlos" sugar plant. [Un programa comunitario de planificacion familiar en el ingenio azucarero "San Carlos".]
  281. Community family planning program. An urban focus. [Programa comunitario de planificacion familiar. Un enfoque urbano.]
  282. Community leaders' attitudes toward family planning.
  283. Community-based distribution of contraceptives: the Thai model.
  284. Community-based distribution of oral contraceptives in Rio Grande do Norte, Northeastern Brazil.
  285. Community-based distribution: the distributive potential and economics of a social marketing approach to family planning.
  286. Community-based family planning. [La planificacion familiar de base comunitaria.]
  287. Comparative effects of intrauterine copper and nylon contraceptive devices on biochemical constituents of rat uterus and fallopian tube.
  288. Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl) [Vergleichende Untersuchungen der oralen Glukosetoleranz und der Serumlipide unter Anwendung eines neuen oralen Kontrazeptivums (SH B 209 AB: 2 mg Cyproteroneacetat 0.05 mg Aethinyloestradiol) der Kombination D-Norgestrol/Aethinyloestradiol und bei einer Kontrollgruppe.]
  289. Comparative study of 4 microdose progestagen - only non-stop oral contraceptives (lynestrenol, D-norgestrel, norethisterone acetate, norgestrienone) on 483 women and 4358 cycles) [Essai comparatif de 4 progestatifs de synthese minidoses en contraception orale "non-stop."]
  290. A comparative study of the effect of oral contraceptives and cigarette smoking onplatelet adhesiveness.
  291. Comparative study of two modern contraceptive methods: a monthly injectable and the Copper T. [Estudio comparitivo de dos modernos metodos anticonceptivos: un inyectable mensual y la "T" de cobre.]
  292. Conclusions and recommendations (on community-based distribution of contraceptives)
  293. Congenital abnormalities and intrauterine contraception.) (Letter to the editor. [Medfodte misdannelser og intrauterin antikonception.]
  294. Congenital malformation associated with intrauterine contraceptive device.
  295. Conjugal role definitions, value of children and contraceptive practice.
  296. Conscientiously study the theory of the dictatorship of the proletariat to promote the work in family planning.
  297. Consensus in the marital dyad: couples' perceptions of contraception, communication, and family life.
  298. Consent and intrauterine contraception.
  299. Considerations when designing a Beyond Family Planning project.
  300. Consultant report on the contraceptive marketing programs in Indonesia and Thailand.
  301. Consumer demand, marketing, and commercial distribution of contraceptives in Pakistan.
  302. Contraception - sterilization. [Contraception - Sterilisation.]
  303. Contraception - why failures?
  304. Contraception after early pregnancy termination) [Contraception apres interruption volontaire de grossesse.]
  305. Contraception and adolescents. [Antikonzeption bei Jugendlichen.]
  306. Contraception and benign breast tumors. [Contraception et tumeurs benignes du sein.]
  307. Contraception and breast cancer. [Contraception et cancer du sein.]
  308. Contraception and cervical carcinoma. [Contraception et cancer du col.]
  309. Contraception and chastity.
  310. Contraception and endometrial carcinoma. [Contraception et cancer de l'endometre.]
  311. Contraception and gynecologic future. [Contraception et avenir gynecologique.]
  312. Contraception and inhibition of ovulation by minipump infusion of the luteinizing hormone releasing hormone, active analogs and antagonists.
  313. Contraception and menopause.
  314. Contraception and pregnancy after dropping out of family planning clinics: a national interview survey in Jamaica.
  315. Contraception and pregnancy interruption in the opinion of women coming for termination of unwanted pregnancy (author's transl) [Antykoncepcja i prezerywanie ciazy w opinii kobiet zglaszajacych sie do zabiegu przerwania ciazy.]
  316. Contraception and the adolescent female.
  317. Contraception by intrauterine devices. [La contraception par les dispositifs intra-uterins.]
  318. Contraception for cancer patients and patients with cancer in remission. [Contraception chez les cancereuses et anciennes cancereuses.]
  319. Contraception for the severely psychiatrically disturbed: confusion, control, and contraindication.
  320. Contraception immediately after voluntary abortion. [La contraception dans les suites immediates d'une interruption volontaire de la grossesse, I.V.G.]
  321. Contraception in 1976. [La contraception en 1976.]
  322. Contraception in ancient India.
  323. Contraception in China.
  324. Contraception in general practice.
  325. Contraception in heart patients. [Contraception chez les cardiaques.]
  326. Contraception in postpartum and postabortion. [Contraception dans le post-partum et le post-abortum.]
  327. Contraception in the future.
  328. Contraception misuse and the clinician.
  329. Contraception of tomorrow - New research trends in the field of birth control. [Kontrazeption morgen - neue Forschungsrichtungen auf dem Gebiet der Gebu rtenkontrolle.]
  330. Contraception sterilisation and abortion in NZ: a review of medical, nursing and related professional policy.
  331. Contraception through vaccination.

     

  332. Contraception under twenty.
  333. Contraception with heart attack patients. [La contraception chez les cardiaques.]
  334. Contraception with injections of medroxyprogesterone acetate.
  335. Contraception with IUDS. [La contraception par dispositif intra-uterin.]
  336. Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian function.
  337. Contraception with norethindrone 0.35 mg administered continuously.
  338. Contraceptive techniques.
  339. Contraceptive technology 1976-1977, 8th revised edition.
  340. Contraceptive technology.
  341. Contraceptive use-effectiveness in Mojokerto Regency, Indonesia: a comparison of regular program and special drive acceptors.
  342. Contraceptive use-efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection.
  343. Contraceptive utilization among currently married women 15-44 years of age: United States, 1973.
  344. Contraceptives and gallstones. (Letter to the editor)
  345. Contraceptives and mammary tumors in mice. [Contraceptifs et tumeurs mammaires chez les souris.]
  346. Contraceptives and the conceptus: 1. Chromosome abnormalities of the fetus and neonate related to maternal contraceptive history.
  347. Contraceptives and thrombosis. [CONTRCEPTIFS ET THROMBOSE.]
  348. Contraceptives. [Los anticonceptivos.]
  349. contraindications of oral contraception. [Contre-indications de la contraception par voie orale.]
  350. The contribution of family planning programs to health: from correlations to casual inference.
  351. Control methods of intrauterine contraceptive devices. [Uber die Kontrollmethoden der intrauterinen Kontrazeptiva.]
  352. A cooperative method of natural birth control. 2nd ed. rev.
  353. The copper T 220C: a new long-acting copper intrauterine contraceptive device.
  354. Cord blood copper concentrations in the presence of a copper-releasing intrauterine contraceptive device.
  355. Cost benefit and cost effectiveness analysis in family planning programs.
  356. Cost effectiveness and cost benefit from the Philippine family planning program.
  357. Cost-benefit analysis of family planning programme in Uttar Pradesh.
  358. The Costa Rican family planning program.
  359. The Council of Europe on fertility and family planning.
  360. Counselling for family planning.
  361. Counselling techniques in family planning.
  362. Countering rumors about contraceptives.
  363. Countering rumors about contraceptives.
  364. Country profile: the Family Planning Association of Hong Kong.
  365. Couples' perceptions of the influence of the use of fertility awareness methods of natural family planning on their marital relationship.
  366. Cross cultural comparison of birth control effectiveness.
  367. Cuba: family planning spur to maternal, child health.
  368. Culture and contraceptives. (Letter to the editor.)
  369. A current appraisal of side effects of oral contraceptives.
  370. Current knowledge of intrauterine contraception. [Danasnja saznanja o intrauterionoj kontracepciji.]
  371. Current participation of midwives and traditional birth attendants in maternal and child health and family planning programmes (in Afghanistan)
  372. Current participation of midwives and Traditional Birth Attendants in maternal and child health and family planning programmes (in Iran)
  373. Current participation of midwives and traditional birth attendants in maternal and child health and family planning programmes (MCH/FP): the functions and responsibilities of midwives and other personnel that provide midwifery care in urban and rural areas in Pakistan.
  374. Current status and limitations of contraception. [Etat actuel et limites de la contraception.]
  375. Current status of oral contraceptive steroids.
  376. Current status of oral contraceptive.
  377. Current status of oral contraceptive.
  378. Current status of use of contraceptives by type of contraceptives.
  379. Cytological effects of the oral contraceptive.
  380. Cytological follow-up of 200 women using copper device for contraception.
  381. Cytological studies in women using intrauterine contraception.
  382. D-norgestrel: an estrogen-free, cyclic oral contraceptive.
  383. The Danfa family planning program in rural Ghana.
  384. Data and analyses for 1976 revision of DHEW five-year plan for family planning services.
  385. Decree No. 76-682 of 19 July 1976 on the higher Council on Sex Education, Birth Control, and Family Education.
  386. Demand for sterilization increases family planning services at the Hasan Sadikin Hospital, Bandung. [Peranan sterilisasi dalam peningkatan pelayanan keluarga berencana di R.S. Hasan Sadikin Bandung.]
  387. Demographic and contraceptive innovators: a study of transitional African society.
  388. Demographic and socioeconomic profile of participants of the Family Planning Program of the Department of Social Assistance: implications and impact of the program. [Perfil socioeconomico y demografico de las usuarias del Programa de Planifcacion Familiar de la SSA: implicaciones para el impacto del Programa.]
  389. Demonstration of gonadotropin during the second half of the cycle in women using intrauterine contraception.
  390. Demonstration of gonadotropin during the second half of the cycle in women using intrauterine contraception. (Abstract only)
  391. The Department of Health National Family Planning Project Office.
  392. Depressive syndrome induced by oral contraceptives.
  393. Dermatosis with contraception. [Dermatosi da contraccettivi.]
  394. Desire for a child and the practice of family planning. [Kinderwunsch und praxis der Familienplanung.]
  395. Detection of breast disease in a family planning association clinic.
  396. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
  397. Developing world family planning programs: status, 1976.
  398. The development of a pelvic model for family planning motivation.
  399. Development of a plan for family planning training and educational activities in Senegal.
  400. Development of the National Inventory of Family Planning services: United States.
  401. Developments in the IPPF. 3. IPPF recommendations of guidelines for the distribution of contraceptives for protection of the users' rights. [Entwicklungen in der IPPF. 3. IPPF Empfehlungen von Richtlinien fuer die Verteilung von Kontraeptiva zum Schutz der Rechts der Vebraucher.]
  402. DHEW inventory shows 4,500 facilities providing medical family planning services - more than half are "specialized."
  403. Diagnostic ultrasound in the management of patients using intrauterine contraceptive devices.
  404. Dialogue a radio program on sex education and family planning of the Family Orientation Center of San Jose, Costa Rica. ["Dialogo" un programa de radio sobre educacion sexual y planificacion familiar del Centro de Orientacion Familiar de San Jose, Costa Rica.]
  405. Differential diagnostic significance of cytogenetic findings for family planning. [Differentialdiagnostischer Wert zytogenetischer Befunde fue die Familienplanung.]
  406. Differentials in the extent and nature of birth control practice, and in the incidence of accidental and unwanted pregnancies, by social class, education and religion.
  407. Differentiated application of oral contraceptives based on the different side effects of synthetic progestins. [Partialwirkung des Gestagenanteils als Kriterium der differenzierten Anwendung von Ovulationshemmern.]
  408. The dilemma of family planning in a North Indian state.
  409. Dilemmas of family planning in a North Indian state.
  410. Diminished urinary calcium excretion by women using oral contraceptives. (Abstract only)
  411. Diosmin in the treatment of accidents associated with contraception. [La diosmine dans le traitement des incidents de la contraception.]
  412. Directory of contraceptives.
  413. Discrete colonic ulcers associated with oral contraceptives.
  414. Discussion of "Contraception and Chastity".
  415. Discussion on new developments in sterilization and contraception.
  416. Disseminated gonococcal infection and tenosynovitis from an asymptomatically infected intrauterine contraceptive device.
  417. Distribution of oral contraceptive pills (letter) [Distribusie van mondelike voorbehoedpille.]
  418. Distribution of oral contraceptives: legal changes and new concepts of preventive care.
  419. A divisional seminar on family planning, Kerewan, North Bank Division, Gambia, April 22-23, 1976.
  420. DMPA as a contraceptive agent: the eight-year controversy continues.
  421. Doctors, contraception, and sterilisation. (Letter to the editor)
  422. Doctors, contraception, and sterilisation. (Letter to the editor)
  423. Doctors, contraception, and sterilisation. (Letter to the editor)
  424. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH.
  425. Down's syndrome and oral contraceptive usage.
  426. Dream recall and the contraceptive pill.
  427. Drug stimulated biotransformation of hormonal steroid contraceptives: clinical implications.
  428. Drug, diet and diagnostic criteria as determinants of folate status of women on oral contraceptives.
  429. Duration of continuous use of intrauterine contraceptives. [O prodolzhitelnosti nepreryvnogo pol'zovaniya vnutrimatochnymi kontratseptivami.]
  430. Duration of use of intrauterine contraception. [K voprosu o dlitelnosti primeneiya vnutrimatochnoi kontratseptsii.]
  431. Dynamics of contraceptive failures.
  432. Early experience with use of norethisterone enanthate as injectable contraceptive in Model Clinic.
  433. Easier access to oral contraceptives.
  434. EEG during menstrual cycle of women with and without oral contraceptives. (Abstract only)
  435. Effect of 1-sarcosine-8-alanine angiotensin 2 on arterial pressure in oral contraceptive-induced hypertension in rats. (Abstract only)
  436. Effect of a long-acting contraceptive drug, norethindrone enanthate, on serum zinc and copper in human volunteers.
  437. Effect of a long-acting contraceptive progestogen on lactation.
  438. Effect of a post-caesarian insertion of intrauterine contraceptive device on the involution of rat uterus.
  439. Effect of an oral contraceptive on alpha-tocopherol levels in rat tissues.
  440. Effect of an oral contraceptive on the lysine-8-vasopressin test in the diagnostic evaluation of pituitary function.
  441. The effect of an oral contraceptive on the pulmonary functions.
  442. Effect of combined hormonal oral contraceptives on several body systems. [Deistrie na kominirani khormonalni oralin kontratseptivni na nyakoi sistemi na organizma.]
  443. The effect of contraceptive steroids and cortisol on tissue distribution of pyridoxal-5'-phosphate in rats. (Abstract only)
  444. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. 2. Carbohydrate and lipid physiology in insulin-dependent diabetics.
  445. Effect of contraceptive steroids on the offspring. [Retentissement des steroides anticonceptionnels sur la descendance.]
  446. The effect of intra-uterine contraceptive devices on the oestrogen-induced incorporation of (tritiated-5) uridine into RNA by the rat uterus.
  447. Effect of intrauterine contraceptive copper and nylon devices on the ionic constituent of the rat uterus.
  448. The effect of kind of carbohydrate in the diet and the use of oral contraceptives on serum lipids, glucose and insulin levels of young women. (Abstract only)
  449. The effect of kind of carbohydrate in the diet and use of oral contraceptives on serum and urinary uric acid and phosphorus levels of young women. (Abstract only)
  450. Effect of long term use of oral contraceptives on glucose tolerance.
  451. Effect of low dosage contraceptive pills on serum pseudocholine esterase level.
  452. The effect of norethisterone (a progesterone-only contraceptive) on the endocrine pancreas of the albino rat.
  453. Effect of oral (combination and progestogen alone) and injectable contraceptives on serum copper levels.
  454. Effect of oral contraceptive hormones on bone and mineral metabolism. ( Abstract only)
  455. Effect of oral contraceptive on the pituitary and plasma l.h. Levels and on the hypothalamic lh-rh level.
  456. Effect of oral contraceptive steroids upon epithelium and mucus.
  457. Effect of oral contraceptives (Lyndiol) on rat brain gamma aminobutyric acid system.
  458. Effect of oral contraceptives and Vitamin B6 supplements on alanine and glycine metabolism.
  459. Effect of oral contraceptives on nutrients: 3. Vitamins B6, B12, and folic acid.
  460. The effect of oral contraceptives on plasma cortisol and cortisol binding capacity throughout the menstrual cycle in normal women.
  461. Effect of oral contraceptives on plasma insulin and blood glucose levels after long-term use. [Seruminsulin und Blutglucose nach Langzeitbehandlung mit Ovulationsblockern.]
  462. Effect of oral contraceptives on platelet monoamine oxidase, monoamine excretion, and adrenocortical function.
  463. Effect of oral contraceptives on rhythmic urinary metal excretion.
  464. The effect of oral contraceptives on the prevalence of rheumatoid factor.
  465. Effect of oral contraceptives on Vitamin B12 binding proteins in human saliva. (Abstract only)
  466. Effect of pregnancy and oral contraceptives on activity of antithrombin 3 and urokinase inhibitor of serum. (Abstract only)
  467. Effect of public family planning on unwanted pregnancies.
  468. Effect of steroid contraceptive on carcinogenesis of the cervix. (Abstract only)
  469. The effect of steroid contraceptives on the concentrations of brain monoamines in rats and mice.
  470. The effect of subsidized family planning services on reproductive behavior in the United States, 1969-1974.
  471. Effect of T-shaped progesterone-releasing system on contraceptive efficacy and menstrual cycle regularity in Japanese monkeys.
  472. The effect of the intra-uterine device and oral contraceptives on the cervical smear. (Abstract only)
  473. The effect of various contraceptive hormonal therapies in women with nor mal and diabetic oral glucose tolerance test.
  474. The effectiveness of family planning education on acceptance of contraception by postpartum mothers.
  475. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women.
  476. The effects of an oral contraceptive, ascorbic acid and iron on glucose and copper metabolism in the rat.
  477. The effects of contraception upon lactation - analysis of urban data.
  478. Effects of contraceptive agents on drug metabolism in various animal species.
  479. Effects of contraceptive pills and intrauterine devices on urinary bladder.
  480. Effects of contraceptive steroids and pregnancy on bile composition and kinetics in the baboon. (Abstract only)
  481. Effects of contraceptive steroids on the renin-angiotensin-aldosterone system. Etiology of hypertension during hormonal contraception. [Veranderungen des Renin-Angiotensin-Aldosteron-Systems unter kontrazeptiven Steroiden. Beitrag zur Atiologie der Hypertonie unter hormonalen Kontrazeptiva.]
  482. Effects of different types of oral contraceptives on ovarian function. [Die Beeinflussung des Ovarialzyklus durch verschiedene Typen hormonaler Kontrazeptiva.]
  483. Effects of oestrogens on prolactin and thyrotrophin responses to TRH in women during the menstrual cycles and under oral contraceptive treatment.
  484. Effects of oral contraceptive agents on trace element metabolism: a review.
  485. Effects of oral contraceptive medication on serum lipids.
  486. Effects of oral contraceptive steroids on pituitary prolactin secretion.
  487. Effects of oral contraceptives on serum protein fractions obtained by electrophoresis.
  488. Effects of oral contraceptives on sexual behavior. [Effets des contraceptifs oraux sur le comportement sexuel.]
  489. Effects of oral contraceptives on the gallbladder bile of normal women.
  490. Effects of oral contraceptives on vitamin metabolism.
  491. Effects of psychotropic drugs on hormonal contraception. [Auswirkungen von Neuropharmaka auf die hormonale Kontrazeption.]
  492. Effects of the oral contraceptive Ovanon on vaginal cytology. [Effets sur la cytologie vaginale d'une contraception oral par Ovanon.]
  493. Efficacy information in contraceptive counseling: those little white lies.
  494. Electroencephalographic correlates of oral contraceptive use in psychiatric patients.
  495. Electron microscopic study of benign hepatoma in a patient on oral contraceptives.
  496. Elevation of serum prolactin during application of oral contraceptives.
  497. Embryotoxicity of leukocyte extracts and its relationship to intrauterine contraception in humans.
  498. Employment and contraceptive practice in selected barrios of Caracas.
  499. Endometrial abnormalities occurring in young women on long-term sequential oral contraception.
  500. Endometrial control: a comparative study of three oral contraceptives.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.